𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum levels of type III collagen aminopropeptide in patients with systemic scleroderma

✍ Scribed by S. Majewski; A. Skiendzielewska; B. Makieŀa; S. Jabŀońska; M. Bŀaszczyk


Publisher
Springer-Verlag
Year
1987
Tongue
English
Weight
273 KB
Volume
279
Category
Article
ISSN
0340-3696

No coin nor oath required. For personal study only.

✦ Synopsis


Systemic scleroderma (SSc) is a connective tissue disease characterized by fibrotic, degenerative, and inflammatory changes in the skin and internal organs [4,9]. Cutaneous fibrosis as well as pathological changes in the internal organs may depend on initital perivascular fibrotic processes followed by excessive deposition of various extracellular matrix proteins [3]. Increased synthesis, deposition, and degradation of collagen, proteoglycans, and fibronectin have been reported in SSc patients [7]. It has been shown that the extent of cutaneous involvement and that of other organs in SSc correlates with an increased synthesis of collagen type I and III in fibroblast cultures derived from patients [2,5,14]. Moreover, it has been reported that enhanced collagen synthesis correlates with the clinical activity of SSc [5], suggesting that measurement of collagen synthesis in a fibroblast culture system may be useful for monitoring the process of fibrosis.

Recently, a new method for the assessment of collagen metabolism was introduced, which may also be useful for monitoring the extent of skin and systemic organ involvement in patients with SSc [6]. This method is based on radioimmunological measurement by antibody Fab fragments of collagen aminopropeptides [11]. The serum level of type III collagen aminopropeptides reflects the rate of collagen synthesis, i.e., the conversion of procollagens into the collagen molecule.

Since this method has been suggested also to be of value for the assessment of the disease activity, the present study was aimed at testing type III collagen aminopropeptide levels in the serum of patients with various forms of SSc, as related to the extent of skin and internal organ involvement.


📜 SIMILAR VOLUMES


Circulating type I collagen degradation
✍ Hunzelmann; Risteli; Risteli; Sacher; Vancheeswaran; Black; Krieg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Systemic sclerosis (SSc; scleroderma) results in the excessive deposition of extracellular matrix components in affected organs. This is partly due to enhanced synthesis; however, the role of degradative processes in this disease is still poorly understood. Sera of 32 patients with SSc (22 with the

Long-Term Follow-Up of Serum N-Terminal
✍ Kurt Weigand; Pierre-Yves Zaugg; Alain Frei; Arthur Zimmermann 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

To evaluate the diagnostic and prognostic significance of the N-terminal propeptide of collagen Type III (Col 1-3) in chronic liver disease, the peptide level was measured in the serum of 4 patients with primary biliary cirrhosis, 5 with chronic persistent hepatitis, 12 with chronic active hepatitis